Skip to content
naulon
Not checkedNot checked for notices yet.

Predictor factors of inappropriate rivaroxaban dosage using the Ckd-Epi equation

Alejandro Isidoro Pérez Cabeza, José Luis Górriz, Rafael Bravo Marqués and 6 more

Nefrología (English Edition) · 2021

doi:10.1016/j.nefroe.2021.04.002 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

n e f r o l o g i a. 2 0 2 1;4 1(2):210-226 demonstrated that rituximab is effective for AAV, especially renal AAV. This is the first case of DLBCL-related AAV with biopsy-proven crescentic glomerulonephritis, and although R- CHOP did not provide lymphoma remission, renal function improved. Thus, rituximab could be effective for improving renal function in AAV. Clinicians should consider the possibility of AAV occurring as a complication in DLBCL.Informed consent was obtained from the patient for the publication of this article.

Abstract licence: CC BY-NC-ND

References5

    5 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.